dataset |
array 1 (# spots filtered
out due to reasons #1 above) |
array 2 (# spots filtered
out due to reasons #1 above) |
array 3 (# spots filtered
out due to reasons #1 above) |
total # spots removed (required
data in >= 2 out of 3 arrays) |
additional # spots removed
due to reasons #2 above (i.e., due to variability) |
additional # spots filtered
out due to SybrGreen I filters #3-5 above |
SybrGreen I |
150 |
244 |
132 |
131 |
0 |
189 |
Rap1 |
40 |
94 |
511 |
23 |
21 |
- |
Abf1 |
1107 |
320 |
439 |
280 |
100 |
- |
Mig1 |
126 |
95 |
92 |
65 |
9 |
- |
dataset | non-duplicate spots with
SybrGreen I (and PBM) data |
average SD/mean |
SybrGreen I |
6449 (95.9%) |
0.130 |
Rap1 |
6431 (95.7%) |
0.323 |
Abf1 |
6142 (91.4%) |
0.282 |
Mig1 |
6442 (95.8%) |
0.202 |
Complementary biotinylated DNA oligonucleotides, each 45 bp in length,
were synthesized such that they contained the predicted Rap1 binding site,
flanked by its native flanking sequence from the given intergenic region.
A positive control probe containing a known Rap1 binding site and a negative
control probe lacking a Rap1 binding site were also synthesized and used
in EMSAs.
The oligonucleotides were diluted in TE, pH 8.0 to a working stock of
10 uM. The working stocks for each of the two complementary oligonucleotides
(designated "-U" for biotinylated "upper", and "-L", for "lower") were
combined in the following ratios, respectively: 1:2 for both control probes
and iYPL221W, and 1:5 for the probe iYLL051C. The solutions were then brought
to a final volume of 20 ul with TE, pH 8.0. Each such pair of single-stranded
complementary oligonucleotides were annealed in a thermocycler according
to the following thermocycling protocol, resulting in approximately 1 uM
final concentration of each biotinylated, double-stranded oligonucleotide:
(1) 94°C for 3 minutes
(2) Ramp down 1°C in 10 seconds (0.1°C per second)
(3) Hold at current temperature for 1 minute
(4) Repeat Steps 2 and 3 to 37°C
(5) 3°C Hold
The annealed oligonucleotide probes were filtered using Millipore's Microcon YM-100 (100,000 MWCO) before use in EMSAs.
The sequences of the oligonucleotides that we used for the Rap1 EMSA probes were as follows:
Positive Control Rap1 binding site:
Rap1-iYHL038C-U
5'ACTTTCACTAAATACACCCATACACACCAATCTTGGATTCTACTC 3'
Rap1-iYHL038C-L
5'GAGTAGAATCCAAGATTGGTGTGTATGGGTGTATTTAGTGAAAGT 3'
Negative Control Rap1 binding site:
Rap1-iYLR288C-U
5'TCCGTATGTTTATGTTGCTATTTTGATGTAAATAAAAAAGTTGAA 3'
Rap1-iYLR288C-L
5'TTCAACTTTTTTATTTACATCAAAATAGCAACATAAACATACGGA 3'
Interesting Probes:
Significant PBM p-value with poor match to PBM derived Rap1 binding site:
Rap1-iYLL051C-U
5'AAACAATGCCCACTAGCCGGGGTGTACGGGACCTTAAATCTAAGT 3'
Rap1-iYLL051C-L
5'ACTTAGATTTAAGGTCCCGTACACCCCGGCTAGTGGGCATTGTTT 3'
Significant PBM p-value with poor match to TRANSFAC derived Rap1 binding site:
Rap1-iYPL221W-U
5'GGGCATACTTTACGGGGTGCACGGATTTTAGCAGTCTTTTTCTTT 3'
Rap1-iYPL221W-L
5'AAAGAAAAAGACTGCTAAAATCCGTGCACCCCGTAAAGTATGCCC 3'
EMSAs were performed according to manufacturer’s protocols for the LightShift©
Chemiluminescent EMSA Kit (Pierce). The "+" lanes correspond to EMSA reactions
that contained approximately 350 nM DNA probe and approximately 29 nM GST-His6-Rap1.
The 'no protein' EMSA reactions ("-" lanes) contained approximately 350 nM
DNA probe and no Rap1 protein. All EMSA binding reactions contained 1x LightShift
Binding Buffer, 0.05 ug/ul poly(dI-dC) nonspecific DNA competitor, 2.5% glycerol,
50 mM KCl, 0.2 ug/ul BSA, 0.05% NP-40, and 0.5 mM zinc acetate. The 20 ul
binding reactions were allowed to sit at room temperature for 1 hour. Subsequently,
2.2 ul of Novex® 5X Hi-Density TBE Sample Buffer (Invitrogen) was added
to the reactions, and 12.5 ul of the reaction was run on a 6% polyacrylamide
DNA retardation gel (Invitrogen) in 0.5X TBE at 100 V for 50 minutes. The
contents of the gel were transferred to a Biodyne® B Pre-cut Modified
Nylon Membrane, 0.45 uM (Pierce), and UV-crosslinked to the membrane at 120
uJ/cm2. The membrane was then treated with developing buffers (Lightshift
Blocking Buffer with stabilized Streptavidin-Horse Radish Peroxidase conjugate,
Wash Buffer, Substrate Equilibration Buffer, Luminol/Enhancer Solution and
Peroxide Solution) according to manufacturer’s protocols. The blot
was promptly exposed to Kodak film for ½ second, which was then developed.